ACH (Accendra Health) Growth Rank: 2 (As of Aug. 07, 2026) — 33% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACH Accendra Health Inc ACH
59 GF Score
Price $2.80
GF Value $5.44
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Accendra Health Growth Rank?

Accendra Health ACH -4.11% 59 Growth Rank is 2 as of Aug. 07, 2026, which is 33% below its 10-year median of 3.00. GuruFocus rates ACH with a GF Score™ of 59/100 and a GF Value™ of $5.44 (Possible Value Trap). The stock has 7 warning signs investors should review.

Accendra Health has the Growth Rank of 2.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Accendra Health Growth Rank Related Terms

ACH vs FOCL, YI, COSM: Growth Rank Comparison

For the Medical Distribution subindustry, Accendra Health's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accendra Health Growth Rank vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Accendra Health's Growth Rank distribution charts can be found below:

* The bar in red indicates where Accendra Health's Growth Rank falls into.


ACH
59GF Score
Accendra Health Inc ACH
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 2 mean?
Accendra Health (ACH) has a Growth Rank of 2 as of Aug. 07, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Accendra Health and its competitors. This is 33% below median its historical median of 3.00. Over the past decade, Accendra Health's Growth Rank has ranged from 1.00 to 7.00.
Is Accendra Health's Growth Rank too high?
Accendra Health's current Growth Rank of 2 is 33% below median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 7.00. Overall, Accendra Health has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Growth Rank compare to FOCL and YI?
Accendra Health's Growth Rank of 2 can be compared against companies in the Medical Distribution industry. Historically, Accendra Health's own Growth Rank has ranged from 1.00 to 7.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Distribution company?
A good Growth Rank depends on the Medical Distribution industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Accendra Health and its competitors. Accendra Health's current Growth Rank is 2, which is 33% below median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.44, compared to a current price of $2.80 — trading 48.5% below its estimated fair value. The current Growth Rank is 2, which is 33% below median its 10-year median of 3.00. Accendra Health's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Accendra Health (ACH), the current Growth Rank is 2 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (ACH) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of $2.80 is trading 48.5% below its estimated GF Value™ of $5.44. GuruFocus considers Accendra Health to be Possible Value Trap.

Key valuation signals for ACH:

  • Growth Rank: 2 (33% below median its 10-year median of 3.00)
  • GF Value™: $5.44 vs. price of $2.80 (48.5% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Accendra Health Business Description

Other Exchanges 6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
59GF Score

Get the complete analysis for ACH

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.80
Price
$5.44
GF Value